PORTOLA PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 42213
 
  
 
C07D HETEROCYCLIC COMPOUNDS 36126
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
C07K PEPTIDES 5131
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 2138
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1108
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,510 PREVENTION AND TREATMENT OF THROMBOSIS IN MEDICALLY ILL PATIENTSMar 10, 17Feb 01, 18[A61K]
2017/0240,879 PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITORDec 27, 16Aug 24, 17[C12N]
2017/0042,896 CERDULATINIB FOR TREATING MYELOMAAug 12, 16Feb 16, 17[A61K]
2016/0354,449 ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAMEJun 08, 16Dec 08, 16[A61K]
2015/0094,298 INHIBITORS OF PROTEIN KINASESDec 05, 14Apr 02, 15[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902688 Benzamides and nicotinamides as Syk modulatorsMay 10, 16Feb 27, 18[C07D, C07C]
9868729 Inhibitors of protein kinasesDec 05, 14Jan 16, 18[A61K, C07D]
9834548 Pyridazine compounds as JAK inhibitorsFeb 12, 15Dec 05, 17[C07D]
9676756 Substituted pyrimidinyl kinase inhibitorsOct 08, 13Jun 13, 17[A61K, C07D]
9644195 Compounds and methods for purification of serine proteasesMay 27, 15May 09, 17[C07D, C12N, B01J]
9587233 Antidotes for factor XA inhibitors and methods of using the sameJul 02, 15Mar 07, 17[A61K, C12N, C07K]
9579320 Inhibitors of syk and JAK protein kinasesDec 19, 14Feb 28, 17[A61K, C07D]
9533986 Bicyclic dihydropyridone kinase inhibitorsSep 27, 13Jan 03, 17[A61K, C07D]
9469654 Bicyclic oxa-lactam kinase inhibitorsSep 27, 13Oct 18, 16[A61K, C07D]
9388401 Antidotes for factor Xa inhibitors and methods of using the sameJul 21, 14Jul 12, 16[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0014,492 UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAMEAbandonedJul 15, 16Jan 19, 17[A61K, C12N]
2016/0237,420 LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTEAbandonedApr 22, 16Aug 18, 16[A61K, C12N]
2016/0015,793 MODULATION OF FACTOR XA INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEAbandonedFeb 14, 13Jan 21, 16[A61K, C12N]
2016/0009,694 CYCLOHEXANEDIAMINE COMPOUNDS AND METHODS FOR THEIR PREPARATIONAbandonedMar 14, 14Jan 14, 16[C07D, C07C]
2015/0376,592 PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITORAbandonedJun 22, 15Dec 31, 15[C12N]
2015/0353,495 NICOTINAMIDES AS JAK KINASE MODULATORSAbandonedJun 29, 15Dec 10, 15[C07D]
2015/0352,194 INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVESAbandonedMar 13, 13Dec 10, 15[A61K]
2015/0239,929 METHOD FOR PURIFICATION OF RECOMBINANT FACTOR XA DERIVATIVESAbandonedJun 12, 13Aug 27, 15[C12N, C07K]
2015/0224,091 PREVENTION AND TREATMENT OF THROMBOSIS IN MEDICALLY ILL PATIENTSAbandonedAug 30, 12Aug 13, 15[A61K]
9023796 Antidotes for factor XA inhibitors and methods of using the sameWithdrawnMay 07, 13May 05, 15[A61K, C12N]
2015/0025,011 UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAMEAbandonedJun 30, 14Jan 22, 15[A61K, C12N]
2014/0346,397 COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASESAbandonedDec 27, 13Nov 27, 14[C12N]
2014/0323,418 SELECTIVE KINASE INHIBITORSAbandonedNov 23, 12Oct 30, 14[C07H, C07D]
2014/0323,497 METHODS AND FORMULATIONS OF TREATING THROMBOSIS WITH BETRIXABAN AND A P-GLYCOPROTEIN INHIBITORAbandonedNov 12, 13Oct 30, 14[A61K]
2014/0221,405 PLATELET ADP RECEPTOR INHIBITORSAbandonedJul 31, 13Aug 07, 14[C07D]
2014/0134,151 ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTSAbandonedApr 30, 13May 15, 14[A61K]
2014/0113,931 SUBSTITUTED PICOLINAMIDE KINASE INHIBITORSAbandonedMar 15, 13Apr 24, 14[C07D]
2013/0317,029 OXYPYRIMIDINES AS SYK MODULATORSAbandonedNov 01, 11Nov 28, 13[C07D]
2013/0252,917 COMBINATION THERAPY OF 4-(3-(2H-1,2,3-TRIAZO-2-YL)PHENYLAMINO)-2-((1R,2S)-2-AMINOCYCLOHEXYLAMINO)PYRIMIDINE-5-CARBOXAMIDE AND FLUDARABINEAbandonedSep 30, 11Sep 26, 13[A61K]
2013/0244,963 COMBINATION THERAPY WITH 4-(3-(2H-1,2,3-TRIAZOL-2-YL)PHENYLAMINO)-2-((1R,2S)-2-AMINOCYCLOHEXYLAMINO)PYRIMIDINE-5-CARBOXAMIDEAbandonedSep 30, 11Sep 19, 13[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.